| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | 0.081 | 0.09 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.09 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.09 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.1 |